Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L3 pseudogene 8 (RPL3P8) is a human processed pseudogene derived from the RPL3 gene, which encodes the ribosomal protein L3, a constituent of the 60S ribosomal subunit[1][2][5][9]. As with many ribosomal protein pseudogenes, RPL3P8 does not produce a functional protein and is considered non-coding[2][11]. There are no known biological functions, disease associations, or roles in therapeutic targeting. RPL3P8 may be transcribed, but such transcription does not produce a functional protein product, and the pseudogene plays no established regulatory or structural function in normal cellular processes or disease[2][11]. Key points: - RPL3P8 is not a receptor, enzyme, or functional protein, and is not considered a drug target. - No disease, biomarker, or drug association has been established for this pseudogene. - The designation is not incorrect—it accurately refers to a known processed pseudogene, but it should not be mistaken for the protein-coding RPL3 or RPL3L genes, which have different biological relevance[4][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L3 pseudogene 8 (RPL3P8).